Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9NQ40: Variant p.Trp17Arg

Solute carrier family 52, riboflavin transporter, member 3
Gene: SLC52A3
Feedback?
Variant information Variant position: help 17 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Tryptophan (W) to Arginine (R) at position 17 (W17R, p.Trp17Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and aromatic (W) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In BVVLS1; loss of riboflavin transport; no effect on localization to cell membrane; does not affect protein abundance. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 17 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 469 The length of the canonical sequence.
Location on the sequence: help MAFLMHLLVCVFGMGS W VTINGLWVELPLLVMELPEG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         MAFLMHLLVCVFGMGSWVTINGLWVELPLLVMELPEG

Mouse                         MAFLTHLLVCVFGMGSWVAINGLWVELPLLVTELPEA

Rat                           MAFLTHLLVCVFGMGSWVAINGLWVELPLLVTKLPEG

Bovine                        MAFLIHLLVCTFGMGSWVAINGLWVELPLLVTELPEG
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 469 Solute carrier family 52, riboflavin transporter, member 3
Transmembrane 3 – 23 Helical



Literature citations
Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment.
Bosch A.M.; Abeling N.G.; Ijlst L.; Knoester H.; van der Pol W.L.; Stroomer A.E.; Wanders R.J.; Visser G.; Wijburg F.A.; Duran M.; Waterham H.R.;
J. Inherit. Metab. Dis. 34:159-164(2011)
Cited for: INVOLVEMENT IN FALOND; INVOLVEMENT IN BVVLS1; VARIANT BVVLS1 ARG-17; Effect of clinical mutations on functionality of the human riboflavin transporter-2 (hRFT-2).
Nabokina S.M.; Subramanian V.S.; Said H.M.;
Mol. Genet. Metab. 105:652-657(2012)
Cited for: CHARACTERIZATION OF VARIANTS BVVLS1 ARG-17; THR-28; LYS-36; LYS-71 AND TRP-132; CHARACTERIZATION OF VARIANT MET-350; FUNCTION; TRANSPORTER ACTIVITY; SUBCELLULAR LOCATION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.